| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |